-
MAPPING THE ATTRIBUTABLE ECONOMIC BURDEN OF OBESITY: A $210 BILLION DISEASE-SPECTRUM ANALYSIS ACROSS CLINICAL CONDITIONS IN CHINA
Aug 11, 2026, 17:16 PM -
REAL-WORLD HEALTHCARE RESOURCE UTILIZATION AND TREATMENT PATTERNS AMONG PATIENTS WITH HIDRADENITIS SUPPURATIVA IN CANADA USING AI-EXTRACTED DATA
Aug 11, 2026, 17:16 PM -
LEVERAGING A NATIONAL REAL-WORLD DATA ASSET LIBRARY TO CHARACTERISE CLINICAL RECOGNISED BUT UNDER-CATEGORISED CONDITIONS IN ELECTRONIC HEALTH RECORDS: A CASE STUDY OF NON-CYSTIC FIBROSIS BRONCHIECTASIS (NCFB) IN CHINA
Aug 11, 2026, 17:16 PM -
SURROGATE-TO-THRESHOLD PRICING: BENCHMARKING THE IGA NEPHROPATHY CASCADE AGAINST A DIALYSIS-REVEALED WILLINGNESS-TO-PAY
Aug 11, 2026, 17:16 PM -
INDIRECT TREATMENT COMPARISON (ITC) OF AUMOLERTINIB VS. OSIMERTINIB IN ADVANCED OR METASTATIC EGFR MUTATED NON-SMALL CELL LUNG CANCER (NSCLC) IN FIRST-LINE AND PREVIOUSLY TREATED SETTINGS
Aug 11, 2026, 17:16 PM -
BEYOND PICO PREDICTION: A SYSTEMATIC FRAMEWORK FOR EVIDENCE GAP ANALYSIS AND STRATEGIC PRIORITIZATION FOR EUROPEAN UNION JOINT CLINICAL ASSESSMENT (EU JCA) READINESS
Aug 11, 2026, 17:16 PM -
DISEASE STATE AWARENESS AND ITS OVERALL IMPACT ON DISEASE MANAGEMENT IN PATIENTS WITH TYPE 2 DIABETESE IN QUETTA, PAKISTAN
Aug 11, 2026, 17:16 PM -
HIDDEN BURDEN OF HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (ATTRV) IN FOUR GULF COUNTRIES: A BURDEN-OF-DISEASE MODELING STUDY
Aug 11, 2026, 17:16 PM -
DIABETES CONTROL AND MORTALITY IN COMMUNITY-DWELLING FRAIL OLDER ADULTS
Aug 11, 2026, 17:16 PM -
AN AI ENABLED DIGITAL TWIN FOR SIMULATING ANTI-VEGF TREATMENT STRATEGIES IN REAL-WORLD NAMD CARE
Aug 11, 2026, 17:16 PM -
BURNOUT AND WORKPLACE SATISFACTION AMONG COMMUNITY PHARMACISTS DURING THE FIRST WAVE OF THE COVID-19 PANDEMIC IN HUNGARY: SCALE DEVELOPMENT AND A NATIONAL CROSS-SECTIONAL STUDY
Aug 11, 2026, 17:16 PM -
ASSESSING THE ENVIRONMENTAL BURDEN OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN SPAIN AND OPPORTUNITIES FOR EMISSION REDUCTION
Aug 11, 2026, 17:16 PM -
SUCCESS FACTORS FOR INDIRECT TREATMENT COMPARISONS IN GERMANY: AN AI-POWERED ANALYSIS
Aug 11, 2026, 17:16 PM -
CHINA'S PHARMACEUTICAL INNOVATION: DOMESTIC AND GLOBAL MARKETING AUTHORIZATION, 2015-2025
Aug 11, 2026, 17:16 PM -
PUBLIC PREFERENCES FOR A NET ZERO HEALTH CARE SERVICE
Aug 11, 2026, 17:16 PM -
ADO2DNET: A LIGHTWEIGHT DEEP LEARNING FRAMEWORK FOR DISTINGUISHING AUTISM SPECTRUM DISORDER (ASD) FROM ATTENTION DEFICIT AND HYPERACTIVITY DISORDER (ADHD) IN ADOLESCENT COHORTS BASED ON RESTING-STATE FMRI IMAGES
Aug 11, 2026, 17:16 PM -
SOCIETY-LEVEL IMPACT OF OCRELIZUMAB IN THE TREATMENT OF MULTIPLE SCLEROSIS IN ALGERIA
Aug 11, 2026, 17:16 PM -
QUALITY-ADJUSTED LIFE EXPECTANCY (QALE) BY ETHNICITY IN ENGLAND: UPDATED ESTIMATES USING THE NEW EQ-5D-5L VALUE SET
Aug 11, 2026, 17:16 PM -
COMPARATIVE SAFETY OF SGLT-2 INHIBITORS VERSUS DPP-4 INHIBITORS FOR ACUTE ELECTROLYTE, GLYCAEMIC AND CLINICAL OUTCOMES IN ACUTE CARE SETTING: A TARGET TRIAL EMULATION
Aug 11, 2026, 17:16 PM -
CAN AI-ASSISTED SLRS MEET HTA STANDARDS? EVIDENCE FROM A NICE SINGLE TECHNOLOGY APPRAISAL
Aug 11, 2026, 17:16 PM
